Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium–intracellulare complex disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium–intracellulare complex disease
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 72, Issue suppl_2, Pages i3-i19
Publisher
Oxford University Press (OUP)
Online
2017-08-24
DOI
10.1093/jac/dkx311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance
- (2017) Shashikant Srivastava et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease
- (2017) Devyani Deshpande et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease
- (2016) Devyani Deshpande et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
- (2016) Julie Jarand et al. CHEST
- Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis,Sui Generis: The Road Ahead
- (2016) Tawanda Gumbo et al. CLINICAL INFECTIOUS DISEASES
- Mortality among patients with pulmonary non-tuberculous mycobacteria disease
- (2016) M. Fleshner et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Semiquantitative Culture Analysis during Therapy forMycobacterium aviumComplex Lung Disease
- (2015) David E. Griffith et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Intermittent Antibiotic Therapy for Nodular BronchiectaticMycobacterium aviumComplex Lung Disease
- (2015) Byeong-Ho Jeong et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Grading the strength of a body of evidence when assessing health care interventions: an EPC update
- (2015) Nancy D. Berkman et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
- (2014) Richard J. Wallace et al. CHEST
- A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients
- (2013) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis
- (2013) H.-B. Xu et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- High-resolution computed tomography and health-related quality of life in Mycobacterium avium complex disease
- (2013) K. Maekawa et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Therapeutic Drug Monitoring in the Treatment ofMycobacterium aviumComplex Lung Disease
- (2012) Won-Jung Koh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance
- (2012) Aurelia M. Schmalstieg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Significance of the Differentiation Between Mycobacterium avium and Mycobacterium intracellulare in M avium Complex Lung Disease
- (2012) Won-Jung Koh et al. CHEST
- Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
- (2012) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic/pharmacodynamic-based treatment of disseminatedMycobacterium avium
- (2011) Devyani Deshpande et al. Future Microbiology
- Development of the RTI item bank on risk of bias and precision of observational studies
- (2011) Meera Viswanathan et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease
- (2011) Mauli Mehta et al. RESPIRATORY MEDICINE
- Pulmonary Nontuberculous Mycobacterial Disease Prevalence and Clinical Features
- (2010) Kevin L. Winthrop et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
- (2010) D. Rebecca Prevots et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Moxifloxacin Pharmacokinetics/Pharmacodynamics and Optimal Dose and Susceptibility Breakpoint Identification for Treatment of Disseminated Mycobacterium avium Infection
- (2010) D. Deshpande et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Toxicodynamic Evidence that High-Dose Pyrazinamide Is Not More Hepatotoxic than the Low Doses Currently Used
- (2010) J. G. Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification by Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium avium
- (2010) D. Deshpande et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Standardized Combination Antibiotic Treatment ofMycobacterium aviumComplex Lung Disease
- (2010) Yun Su Sim et al. YONSEI MEDICAL JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More